Phoenix Biosciences

Nivelles ·KBO/BCE: BE 1027.640.071

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	45.4%	46.8%	better than 49% of 79 sector peers
Net result	€-2.81M	€17k	better than 5% of 78 sector peers
Equity	€3.68M	€78k	better than 91% of 79 sector peers
Total assets	€8.11M	€238k	better than 92% of 79 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€8.11M
Fixed assets	21/28	€1.32M
Intangible fixed assets	21	€1.10M
Tangible fixed assets	22/27	€166k
Financial fixed assets	28	€54k
Current assets	29/58	€6.79M
Stocks & contracts in progress	3	€663k
Amounts receivable within one year	40/41	€1.46M
Cash & bank	54/58	€4.65M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€8.11M
Equity	10/15	€3.68M
Contributions / capital	10/11	€6.49M
Accumulated profits (losses)	14	€-2.81M
Amounts payable	17/49	€4.43M
Amounts payable after one year	17	€3.00M
Amounts payable within one year	42/48	€1.40M
Trade debts payable within one year	44	€498k
Income statement
Turnover	70	€1.30M
Operating result	9901	€-2.80M
Financial income	75	€218
Financial charges	65	€11k
Result before taxes	9903	€-2.81M
Net result for the period	9904	€-2.81M
Result to be appropriated	9905	€-2.81M

Statutory auditor	IRE/IBR number	Tenure
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent Statutory auditor · represented by Rodrigo Abels	-	12-12-2025 → present
Pierre Warzée Réviseur d'entreprisesCurrent Company auditor · represented by Pierre Warzée	-	31-10-2025 → present

Summary

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Public limited company(014)
Incorporation	15-09-2025
Status	Active
Postal code	1400